136 related articles for article (PubMed ID: 25977616)
41. The role of resistance and aerobic exercise training on insulin sensitivity measures in STZ-induced Type 1 diabetic rodents.
Hall KE; McDonald MW; Grisé KN; Campos OA; Noble EG; Melling CW
Metabolism; 2013 Oct; 62(10):1485-94. PubMed ID: 23810201
[TBL] [Abstract][Full Text] [Related]
42. Anti-diabetic effects of globin digest and its active ingredient Leu-Ser-Glu-Leu in ICR mice, streptozotocin-induced diabetic mice and KK-Ay mice.
Nakaoka F; Sasakawa Y; Yamamoto K; Nakao M; Nakamura M; Tong C; Fukuhama C; Kagawa K
Life Sci; 2010 Mar; 86(11-12):424-34. PubMed ID: 20109472
[TBL] [Abstract][Full Text] [Related]
43. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
Piercy V; Toseland CD; Turner NC
Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
[TBL] [Abstract][Full Text] [Related]
44. Effect of a novel insulinotropic agent, succinic acid monoethyl ester, on lipids and lipoproteins levels in rats with streptozotocin-nicotinamide-induced type 2 diabetes.
Saravanan R; Pari L
J Biosci; 2006 Dec; 31(5):581-7. PubMed ID: 17301496
[TBL] [Abstract][Full Text] [Related]
45. The effect of betulinic acid on leptin, adiponectin, hepatic enzyme levels and lipid profiles in streptozotocin-nicotinamide-induced diabetic mice.
Ahangarpour A; Shabani R; Farbood Y
Res Pharm Sci; 2018 Apr; 13(2):142-148. PubMed ID: 29606968
[TBL] [Abstract][Full Text] [Related]
46. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
[TBL] [Abstract][Full Text] [Related]
47. Effects of crocin and voluntary exercise, alone or combined, on heart VEGF-A and HOMA-IR of HFD/STZ induced type 2 diabetic rats.
Ghorbanzadeh V; Mohammadi M; Dariushnejad H; Chodari L; Mohaddes G
J Endocrinol Invest; 2016 Oct; 39(10):1179-86. PubMed ID: 27094045
[TBL] [Abstract][Full Text] [Related]
48. Protective effects of either C-peptide or l-arginine on pancreatic β-cell function, proliferation, and oxidative stress in streptozotocin-induced diabetic rats.
Ragy MM; Ahmed SM
J Cell Physiol; 2019 Jul; 234(7):11500-11510. PubMed ID: 30515793
[TBL] [Abstract][Full Text] [Related]
49. Effect of Acacia nilotica leaves extract on hyperglycaemia, lipid profile and platelet aggregation in streptozotocin induced diabetic rats.
Asad M; Aslam M; Munir TA; Nadeem A
J Ayub Med Coll Abbottabad; 2011; 23(2):3-7. PubMed ID: 24800330
[TBL] [Abstract][Full Text] [Related]
50. Transplantation of human dental pulp stem cells in streptozotocin-induced diabetic rats.
El-Kersh AOFO; El-Akabawy G; Al-Serwi RH
Anat Sci Int; 2020 Sep; 95(4):523-539. PubMed ID: 32476103
[TBL] [Abstract][Full Text] [Related]
51. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
Amoah AG; Owusu SK; Schuster DP; Osei K
S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
[TBL] [Abstract][Full Text] [Related]
52. ZB-16, a Novel GPR119 Agonist, Relieves the Severity of Streptozotocin-Nicotinamide-Induced Diabetes in Rats.
Tyurenkov IN; Kurkin DV; Bakulin DA; Volotova EV; Chafeev MA; Smirnov AV; Morkovin EI
Front Endocrinol (Lausanne); 2017; 8():152. PubMed ID: 28736546
[TBL] [Abstract][Full Text] [Related]
53. Effects of the combination of dipeptidyl peptidase-IV inhibitor ASP8497 and antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic mice.
Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Hayakawa M; Shibasaki M
Eur J Pharmacol; 2009 Mar; 605(1-3):170-6. PubMed ID: 19171131
[TBL] [Abstract][Full Text] [Related]
54. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.
Choi WS; Lee JJ; Kim Y; Kim IS; Zhang WY; Myung CS
Arch Pharm Res; 2011 Apr; 34(4):615-24. PubMed ID: 21544727
[TBL] [Abstract][Full Text] [Related]
55. Exenatide upregulates gene expression of glucagon-like peptide-1 receptor and nerve growth factor in streptozotocin/nicotinamide-induced diabetic mice.
Gumuslu E; Cine N; Ertan M; Mutlu O; Komsuoglu Celikyurt I; Ulak G
Fundam Clin Pharmacol; 2018 Apr; 32(2):174-180. PubMed ID: 29091313
[TBL] [Abstract][Full Text] [Related]
56. Metabolic disturbances and defects in insulin secretion in rats with streptozotocin-nicotinamide-induced diabetes.
Szkudelski T; Zywert A; Szkudelska K
Physiol Res; 2013; 62(6):663-70. PubMed ID: 23869889
[TBL] [Abstract][Full Text] [Related]
57. Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic mice.
Novelli M; Canistro D; Martano M; Funel N; Sapone A; Melega S; Masini M; De Tata V; Pippa A; Vecoli C; Campani D; De Siena R; Soleti A; Paolini M; Masiello P
Eur J Pharmacol; 2014 Apr; 729():37-44. PubMed ID: 24530416
[TBL] [Abstract][Full Text] [Related]
58. Evaluating insulin secretagogues in a humanized mouse model with functional human islets.
Luo J; Nguyen K; Chen M; Tran T; Hao J; Tian B; Rulifson IC; Zhang Y; Tian L; Zhang Y; Lopez E; Lin DC; Wang Y; Ma Z; Houze J; Guo Z
Metabolism; 2013 Jan; 62(1):90-9. PubMed ID: 22982177
[TBL] [Abstract][Full Text] [Related]
59. Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter.
Tozzo E; Gnudi L; Kahn BB
Endocrinology; 1997 Apr; 138(4):1604-11. PubMed ID: 9075721
[TBL] [Abstract][Full Text] [Related]
60. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat.
Hassan N; Janjua MZ
J Ayub Med Coll Abbottabad; 2001; 13(3):26-30. PubMed ID: 11873395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
